Study suggests caution on a new anti-obesity drug in children

May 07, 2008

A new class of anti-obesity drugs that suppresses appetite by blocking cannabinoid receptors in the brain could also suppress the adaptive rewiring of the brain necessary for neural development in children, studies with mice have indicated. One such drug, rimonabant (trade name Acomplia) has been developed by Sanofi-Aventis and is awaiting approval for use in the U.S., and other pharmaceutical companies are developing similar drugs.

Mark Bear and colleagues published their findings in the May 8, 2008, issue of the journal Neuron, published by Cell Press.

The principal aim of the researchers’ experiments was to gain insight into regulation of the process called “experience-dependent cortical plasticity” in the brain. Such plasticity is the adaptive rewiring of the brain caused by experience that is central to neural development in children and young animals.

For their experimental model, the researchers used plasticity in the visual cortex of the mouse. The visual cortex is the brain region that processes visual signals from the eye, adapting to experience. To study visual cortex plasticity, the researchers used the long-known phenomenon that closing an eye in a young animal causes that eye to lose visual responsiveness—known as a shift in “ocular dominance (OD)—as the visual cortex rapidly adapts due to its plasticity. Specifically, the researchers wanted to understand the regulation of plasticity in two layers, or lamina, of the visual cortex called 2/3 and 4. Also, they knew that activity of the cannabinoid receptor plays a role in plasticity by regulating the signaling connections among neurons.

In their experiments, the researchers closed one eye of an animal and measured the effect on plasticity using recording electrodes implanted in the layers of the visual cortex.

It had been previously believed that plasticity in layer 2/3 was required for plasticity in layer 4. However, the researchers found that when they used a drug called AM 251 to block the cannabinoid receptors in the animals’ brains, plasticity in layer 2/3 was suppressed, but plasticity in layer 4 was unaffected.

“These findings simplify the mechanistic description of plasticity in layer 4, force a revision in the interpretation of previous studies in which laminar differences in OD plasticity mechanisms were unrecognized, and have important implications for the therapeutic use of cannabinoid receptor antagonists in humans,” concluded Bear and colleagues.

Citing the development of obesity drugs that block cannabinoid receptors, the researchers cautioned that “Our finding of a profound disruption of cortical plasticity in juvenile mice treated with AM 251 suggests caution is advised in the use of such compounds in children.”

Source: Cell Press

Explore further: FDA approves new drugs for irritable bowel syndrome

Related Stories

Wood-polymer composite furniture with low flammability

May 04, 2015

Wood is a popular material in interior design, but its water absorbency limits its use in bathrooms, where natural wood easily becomes discolored or moldy. Fraunhofer scientists and partners have developed ...

Researchers explain skin fusion at a molecular level

Apr 21, 2015

Scientists from the Goethe University (GU) Frankfurt, the European Molecular Biology Laboratory (EMBL) Heidelberg and the University of Zurich explain skin fusion at a molecular level and pinpoint the specific ...

IceBridge overflies Norwegian camp on drifting sea ice

Mar 27, 2015

Studying sea ice in the Fram Strait, a passage between Greenland and Svalbard that is the main gateway for Arctic sea ice into the open ocean, is not easy. In this area, not only does ice flow southward quickly ...

Recommended for you

US appeals court upholds delay in Alzheimer's drug swap

May 22, 2015

A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires this summer.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

sheber
not rated yet May 07, 2008
Why teach our kids to exercise and eat right when we can just give them another pill?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.